Pharmaceutical UK pharma major GlaxoSmithKline and French peer Servier have reached an agreement for increase the production of dolutegravir, which is a drug for the treatment of HIV at the facilities of Servier RUS plant in Moscow, according to recent statements by the press service of the Department of Investment and Industrial Policy of the Moscow city government. 29 June 2021